Impaired uterine arterial blood flow in pregnant women with recurrent pregnancy loss

Journal of Ultrasound in Medicine

Volumn 22, Issue 1, 2003, Pages 27-31

  Nakatsuka, Mikiya ^a   Habara, Toshihiro ^a   Noguchi, Soichi ^a   Konishi, Hideki ^a   Kudo, Takafumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Antinuclear antibodies; Antiphospholipid antibodies; Pulsed Doppler ultrasonography; Recurrent pregnancy loss; Uterine artery

Indexed keywords

BLOOD; MEDICAL PROBLEMS; NONINVASIVE MEDICAL PROCEDURES; ULTRASONIC APPLICATIONS;

ULTRASONOGRAPHY;

BIOMEDICAL ENGINEERING;

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; PHOSPHOLIPID ANTIBODY;

ACOUSTIC IMPEDANCE; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PULSATILE FLOW; RECURRENT ABORTION; SCORING SYSTEM; TRANSVAGINAL ECHOGRAPHY; UTERINE ARTERY; UTERUS BLOOD FLOW; VASCULAR DISEASE; VASCULAR RESISTANCE;

EID: 0037247862     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2003.22.1.27     Document Type: Article

References (26)

1. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989; 256:H1060-H1065.
2. Jurkovic D, Jauniaux E, Kurjak A, Hustin J, Campbell S, Nicolaides KH. Transvaginal color Doppler assessment of the uteroplacental circulation in early pregnancy. Obstet Gynecol 1991; 77:365-369.
3. Steel SA, Pearce JM, McParland P, Chamberlain GV. Early Doppler ultrasound screening in prediction of hypertensive disorders of pregnancy. Lancet 1990; 335:1548-1551.
4. van den Elzen HJ, Cohen-Overbeek TE, Grobbee DE, Quartero RW, Wladimiroff JW. Early uterine artery Doppler velocimetry and the outcome of pregnancy in women aged 35 years and older. Ultrasound Obstet Gynecol 1995; 5:328-333.
5. Hamington K, Goldfrad C, Carpenter RG, Campbell S. Transvaginal uterine and umbilical artery Doppler examination of 12-16 weeks and the subsequent development of pre-eclampsia and intrauterine growth retardation. Ultrasound Obstet Gynecol 1997; 9:94-100.
6. van den Elzen HJ, Cohen-Overbeek TE, Grobbee DE, Wladimiroff JW. The predictive value of uterine artery flow velocity waveforms in miscarriage in older women. Br J Obstet Gynaecol 1993; 100:762-764.
7. Jauniaux E, Zaidi J, Jurkovic D, Campbell S, Hustin J. Comparison of colour Doppler features and pathological findings in complicated early pregnancy. Hum Reprod 1994; 9:2432-2437.
8. Kurjak A, Zalud I, Predanic M, Kupesic S. Transvaginal color and pulsed Doppler study of uterine blood flow in the first and early second trimesters of pregnancy: normal versus abnormal. J Ultrasound Med 1994; 13:43-47.
9. Leible S, Cumsille F, Walton R, Munoz H, Jankelevich J, Sepulveda W. Discordant uterine artery velocity waveforms as a predictor of subsequent miscarriage in early viable pregnancies. Am J Obstet Gynecol 1998; 179:1587-1593.
10. Alcázar JL, Ruiz-Perez ML. Uteroplacental circulation in patients with first-trimester threatened abortion. Fertil Steril 2000; 73:130-135.
11. Frates MC, Doubilet PM, Brown DL, et al. Role of Doppler ultrasonography in the prediction of pregnancy outcome in women with recurrent spontaneous abortion. J Ultrasound Med 1996; 15:557-562.
12. Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T. Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod 2002; 17:190-194.
13. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993; 100:909-913.
14. Coulam CB, Clark DA, Beer AE, et al. Current clinical options for diagnosis and treatment of recurrent spontaneous abortion. Am J Reprod Immunol 1997; 38:57-74.
15. Carroll BA. Obstetric duplex sonography in patients with lupus anticoagulant syndrome. J Ultrasound Med 1990; 9:17-21.
16. Caruso A, De Carolis S, Ferrazzani S, Valesini G, Caforio L, Mancuso S. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 1993; 82:970-977.
17. Venkat-Raman N, Backos M, Teoh TG, Lo WT, Regan L. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet Gynecol 2001; 98:235-242.
18. Farrell T, Dawson T. Can uterine artery Doppler velocimetry predict adverse pregnancy outcome in women with antiphospholipid syndrome? Acta Obstet Gynecol Scand 2001; 80:609-610.
19. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42:1309-1311.
20. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93:1049-1059.
21. Jauniaux E, Jurkovic D, Campbell S, Hustin J. Doppler ultrasonographic features of the developing placental circulation: correlation with anatomic findings. Am J Obstet Gynecol 1992; 166:585-587.
22. Dickey RP, Hower JF. Effect of ovulation induction on uterine blood flow and oestradiol and progesterone concentrations in early pregnancy. Hum Reprod 1995; 10:2875-2879.
23. Ogasawara M, Aoki K, Kajima S, Yagami Y. Are antinuclear antibodies predictive of recurrent miscarriage? Lancet 1996; 347:1183-1184.
24. Bar J, Mashiah R, Cohen-Sacher B, et al. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb Res 2001; 101:235-241.
25. Nakatsuka M, Tada K, Kimura Y, et al. Clinical experience of long-term transdermal treatment with NO donor for women with preeclampsia. Gynecol Obstet Invest 1999; 47:13-19.
26. Nakatsuka M, Takata M, Tada K, et al. A long-term transdermal nitric oxide donor improves uteroplacental circulation in women with preeclampsia. J Ultrasound Med 2002; 21:831-836.